NADINE ALASHKER: Open Payments
NPI 1114485851 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,645 in 183 payments from 15 companies in 2025. Trend: 2023 $3,525 · 2024 $3,893 · 2025 $4,645
Food & beverage: $4,313Consulting: $175Travel & lodging: $157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $1,248 |
| Novartis Pharmaceuticals Corporation | 24 | $839 |
| Amgen Inc. | 32 | $764 |
| UCB, Inc. | 25 | $444 |
| GENZYME CORPORATION | 7 | $363 |
| Janssen Biotech, Inc. | 14 | $260 |
| GlaxoSmithKline, LLC. | 13 | $240 |
| Lilly USA, LLC | 6 | $148 |
| Mallinckrodt Hospital Products Inc. | 5 | $118 |
| PFIZER INC. | 4 | $84 |
Products named: RINVOQ, SKYRIZI, COSENTYX, Bimzelx, KEVZARA, TREMFYA, BENLYSTA, PROLIA.
Industry payments across FL — which companies pay providers there.
